Printer Friendly
The Free Library
14,695,195 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CTX-M [beta]-lactamase-producing Escherichia coli in long-term care facilities, France.


To the Editor: In tong-term care facilities, most endemic infections affect respiratory and urinary tracts, as well as skin and soft tissues (1-3). Infection and colonization by antimicrobial-resistant organisms, in particular those producing plasmid-mediated extended-spectrum [beta]-lactamases (ESBL ESBL Extended Spectrum Beta Lactamase
ESBL East Staffordshire Badminton League (UK) 
), are common in long-term care facilities (4). Since 1984, ESBL-producing Enterobacteriaceae have spread among French hospitals; within Parisian public hospitals (Assistance Publique, Hopitaux de Paris), ESBL-producing Escherichia coli is the most frequent species found, representing 49.5% of 220 Enterobacteriaceae isolated in 2002, mostly in urinary tract infections (5). Among ESBL-producing Enterobacteriaceae, CTX-M type [beta]-lactamases confer a higher level of resistance to cefotaxime and ceftriaxone ceftriaxone /cef·tri·ax·one/ (cef?tri-ak´son) a semisynthetic, ß–resistant, third-generation cephalosporin effective against a wide range of gram-positive and gram-negative bacteria, used as the sodium salt.  than to ceftazidime. CTX-M-producing strains are endemic in Latin America, Japan, and certain parts of Eastern Europe; in contrast, these strains are emerging in France, Western Europe, and the United States (6). We report the first documented outbreak of CTX-M-producing E. coli infection in a long-term care facility in France. Our hospital is an 800-bed institution with 300 beds for long-term patients distributed among three units located in two buildings. The outbreak occurred in a 35-bed unit and involved 26 of 47 hospitalized patients from October 2001 to March 2003. This facility hosts patients for extended periods of time or permanently. The index case was identified in October 2001; the patient had a urinary tract infection attributable to an ESBL-producing E. coli, which showed resistance patterns not previously found in our hospital. Three new cases were detected within the following 2 months, and all patients had urinary tract infection with the same pattern of resistance. In January 2002, patients were screened for ESBL-producing strains by rectal swabbing and urine culture. The results showed E. coli with a high level of resistance to amoxicillin amoxicillin /amox·i·cil·lin/ (ah-mok?si-sil´in) a semisynthetic derivative of ampicillin effective against a broad spectrum of gram-positive and gram-negative bacteria.

a·mox·i·cil·lin
n.
 and ticarcillin (MIC > 128 [micro]g/mL), partial restoration of susceptibility to these agents by addition of clavulanic acid (MIC = 16-32 [micro]g/mL), and higher resistance to cefotaxime (MIC > 128 [micro]g/mL) than to ceftazidime (MIC = 32-64 [micro]g/mL.) A cephalosporin/coamoxiclav synergy test was positive, which suggests a CTX-M ESBL. Strains were also resistant to ciprofloxacin ciprofloxacin /cip·ro·flox·a·cin/ (sip?ro-flok´sah-sin) a synthetic antibacterial effective against many gram-positive and gram-negative bacteria; used as the hydrochloride salt.

cip·ro·flox·a·cin
n.
 (MIC 64 [micro]g/mL) and gentamicin gentamicin /gen·ta·mi·cin/ (jen?tah-mi´sin) an aminoglycoside antibiotic complex isolated from bacteria of the genus Micromonospora,  (MIC > 64 [micro]g/mL) but remained susceptible to trimethoprimsulfamethoxazole.

Attempts to transfer resistance to [beta]-lactams by conjugation conjugation, in genetics
conjugation, in genetics: see recombination.
conjugation, in grammar
conjugation: see inflection.
 to E. coli J53-2 with the 26 strains tested were unsuccessful. In contrast, transformants were obtained with plasmid DNA of the 19 strains tested by electroporation electroporation (i·lekˈ·trō·p·rāˑ·sh . The transformants' susceptibility pattern was similar to that of the donor strains, except for ciprofloxacin resistance. Analytical isoelectric focusing showed that all clinical strains and transformants had bands of [beta]-lactamase activity with an alkaline pl of 7.6 and 5.4. Polymerase chain reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is  (PCR PCR polymerase chain reaction.

PCR
abbr.
polymerase chain reaction


Polymerase chain reaction (PCR) 
) amplification of the 26 clinical isolates was positive for [bla.sub.CTX-M] and [bla.sub.TEM TEM

1. transmission electron microscope.

2. triethylenemelamine.

3. transmissible encephalopathy of mink.
] (7). The 26 strains of E. coli had the same profile by repetitive-element PCR and pulsed-field gel electrophoresis, while unrelated control strains had very different profiles. Sequencing in strains isolated from four of the patients identified a CTX-M-15 [beta]-lactamase and a TEM-1 [beta]-lactamase. The four strains were related to the phylogenetic group B2 and produced the iutA (ferric ferric (fĕr`ĭk), iron in the +3 valence state.


See ferrous.
 aerobactin receptor), YuA (Yersinia Yersinia

A genus of bacteria in the Enterobacteriaceae family. The bacteria appear as gram-negative rods and share many physiological properties with related Escherichia coli. Of the 11 species of Yersinia, Y. pestis, Y. enterocolitica, and Y.
 siderophore siderophore /sid·ero·phore/ (sid´er-o-for?) a macrophage containing hemosiderin.

sid·er·o·phore
n.
A large, extravasated, mononuclear phagocyte containing a granule of hemosiderin.
 receptor), and film (type 1 fimbriae) virulence lactors (8). Incidence of colonization or infection by the culprit strain was 34.3% (12 of 35 patients) within the initial 4-month period and 55.3% (26 of 47 patients) over a 1-year period.

Intensified hygienic procedures implemented in January 2002 contributed to a decrease in the number of cases in February only; since then, a regular increase of new cases extended the outbreak and caused problems with controlling it. All urinary tract infections were successfully treated with a 15-day course of trimethoprimsulfamethoxazole; however, reinfection reinfection /re·in·fec·tion/ (-in-fek´shun) a second infection by the same agent or a second infection of an organ with a different agent.

re·in·fec·tion
n.
 occurred in some. Neither incontinence (p = 0.35), dementia (p = 0.22), nor previous antibiotic treatment (amoxicillin, amoxicillin-clavulanic acid, extended-spectrum cephalosporins Cephalosporins Definition

Cephalosporins are medicines that kill bacteria or prevent their growth.
Purpose

Cephalosporins are used to treat infections in different parts of the body—the ears, nose, throat, lungs, sinuses, and
, and fluoroquinolones [p = 1.00, 0.30, 0.12, 0.52, respectively]) appeared to be risk factors for infection or colonization in our study, but the number of patients is too small to reach a conclusion. However, patients that were infected or colonized Colonized
This occurs when a microorganism is found on or in a person without causing a disease.

Mentioned in: Isolation
 had greater functional impairment, especially incontinence and dementia. Nonambulatory status, decubitus ulcers, and feeding tubes were not risk factors for acquiring ESBL-producing E. coli in our study.

The outbreak has not been controlled: 13 patients have persistent digestive-tract colonization. Difficulties encountered in controlling such outbreaks may be explained by several factors. Patients cannot be easily isolated in long-term care facilities. Strict isolation and limitation of activity and mobility cannot always be applied because of their impact on social activities.

Acknowledgments

We thank Abel Naas for helping to collect the clinical information and Claudia Ferreira for helping to write this letter.

Najiby Kassis-Chikhani, * Sophie Vimont, [(dagger)], Karine Asselat, * Christophe Trivalle, * Beredia Minassian, * Christian Sengelin, * Valerie Gautier, [(double dagger]), Daniele Mathieu, * Elisabeth Dussaix, * and Guillaume Arlet, [(double dagger])

* Hopital Paul Brousse, Villejuif, France; ([dagger]) Hopital Tenon, Paris, France; and ([dagger]) Universite Paris VI, Paris, France

References

(1.) Nicolle LE, Garibaldi R, Strausbaugh L.I. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 1996;9:1-17.

(2.) Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis. 2000;31: 752-6.

(3.) Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105:319-30.

(4.) Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic resistant Klehsiella and Escherichia coil in nursing homes. JAMA JAMA
abbr.
Journal of the American Medical Association
. 1999;281:563-4.

(5.) Gutmann L, Jarlier V, Nicolas-Chanoine MH, Soussy CJ. Staphylocoques dores et klebsielles A I'AP-HP. Resultats de l'enquete 2002. Department of Microbiology, Assistance Publique, Hopitaux de Paris; 2003.

(6.) Bonnet R, Growing group of extended spectrum beta-lactamases: CTX-M enzymes. Antimicrob Agents Chemother. 2004; 48:1-14.

(7.) Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, et al. Dissemination of CTX-M-Type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother. 2004;48:1249-55.

(8.) Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E. coli." J Lab Clin Med. 2002;139: 155-62.

Address for correspondence: Najiby Kassis-Chikhani, Hopital Paul Brousse, Service de Microbiologie, 12 Ave P.V. Couturier 94804, Villejuif Cedex, France; fax: 33-1-45-59-37-24; email: najiby.kassis-chikhani@pbr.ap-hopparis.fr
COPYRIGHT 2004 U.S. National Center for Infectious Diseases
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters
Author:Arlet, Guillaume
Publication:Emerging Infectious Diseases
Article Type:Letter to the Editor
Date:Sep 1, 2004
Words:1039
Previous Article:Rubella epidemic strain, Greece, 1999.(Letters)(Letter to the Editor)
Next Article:Do antiborrelial antibodies suggest Lyme disease in Cuba?(Letters)(Letter to the Editor)



Related Articles
Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan. (Research).
Cephalosporin-resistant Escherichia coli among summer camp attendees with Salmonellosis.(Research)
Escherichia coli producing CTX-M-2 [beta]-lactamase in Cattle, Japan.(Research)
CTX-M-type [beta]-lactamases affect community Escherichia coli treatment, Greece.(Letters)(Letter to the Editor)
CTX-M and plasmid-mediated AmpC-producing Enterobacteriaceae, Singapore.(Letters)(Letter to the Editor)
Genetic background of Escherichia coli and extended-spectrum [beta]-lactamase type.(Research)
Enterobacter cloacae outbreak and emergence of quinolone resistance gene in Dutch hospital.
Extended-spectrum [beta]-lactamase--producing Enterobacteriaceae, Central African Republic.(LETTERS)(Disease/Disorder overview)
Ertapenem resistance of Escherichia coli.(DISPATCHES)
Population-based laboratory surveillance for AmpC [beta]-lactamase-producing Escherichia coli, Calgary.(RESEARCH)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles